Article: Effects of the natural flavone trimethylapigenin on cardiac potassium currents

File Download
  • No File Attached
Links for fulltext
(May Require Subscription)
Supplementary

  • Basic View
  • Metadata View
  • XML View
TitleEffects of the natural flavone trimethylapigenin on cardiac potassium currents
AuthorsLiu, Y2 3
Xu, XH3
Liu, Z4
Du, XL4
Chen, KH2 3
Xin, X2 3
Jin, ZD3
Shen, JZ2 3
Hu, Y2 3
Li, GR1
Jin, MW2 3
KeywordsAcetylcholine-Activated K + Current
Hkv1.5
Open Channel Blocker
Trimethylapigenin
Issue Date2012
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/biochempharm
CitationBiochemical Pharmacology, 2012, v. 84 n. 4, p. 498-506 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.bcp.2012.05.002
AbstractThe natural flavones and polymethylflavone have been reported to have cardiovascular protective effects. In the present study, we determined whether quecertin, apigenin and their methylated compounds (3,7,3′,4′-tetramethylquecertin, 3,5,7,3′,4′-pentamethylquecertin, 7,4′-dimethylapigenin, and 5,7,4′-trimethylapigenin) would block the atrial specific potassium channel hKv1.5 using a whole-cell patch voltage-clamp technique. We found that only trimethylapigenin showed a strong inhibitory effect on hKv1.5 channel current. This compound suppressed hKv1.5 current in HEK 293 cell line (IC 50 = 6.4 μM), and the ultra-rapid delayed rectify K + current I Kur in human atrial myocytes (IC 50 = 8.0 μM) by binding to the open channels and showed a use- and frequency-dependent manner. In addition, trimethylapigenin decreased transient outward potassium current (I to) in human atrial myocytes, inhibited acetylcholine-activated K + current (IC 50 = 6.8 μM) in rat atrial myocytes. Interestingly, trimethylapigenin had a weak inhibition of hERG channel current. Our results indicate that trimethyapigenin significantly inhibits the atrial potassium currents hKv1.5/I Kur and I KACh, which suggests that trimethylapigenin may be a potential candidate for anti-atrial fibrillation. © 2012 Elsevier Inc. All rights reserved.
ISSN0006-2952
2011 Impact Factor: 4.705
2011 SCImago Journal Rankings: 0.418
DOIhttp://dx.doi.org/10.1016/j.bcp.2012.05.002
DC Field
Value
dc.contributor.authorLiu, Y
dc.contributor.authorXu, XH
dc.contributor.authorLiu, Z
dc.contributor.authorDu, XL
dc.contributor.authorChen, KH
dc.contributor.authorXin, X
dc.contributor.authorJin, ZD
dc.contributor.authorShen, JZ
dc.contributor.authorHu, Y
dc.contributor.authorLi, GR
dc.contributor.authorJin, MW
dc.date.accessioned2012-09-05T05:32:16Z
dc.date.available2012-09-05T05:32:16Z
dc.date.issued2012
dc.description.abstractThe natural flavones and polymethylflavone have been reported to have cardiovascular protective effects. In the present study, we determined whether quecertin, apigenin and their methylated compounds (3,7,3′,4′-tetramethylquecertin, 3,5,7,3′,4′-pentamethylquecertin, 7,4′-dimethylapigenin, and 5,7,4′-trimethylapigenin) would block the atrial specific potassium channel hKv1.5 using a whole-cell patch voltage-clamp technique. We found that only trimethylapigenin showed a strong inhibitory effect on hKv1.5 channel current. This compound suppressed hKv1.5 current in HEK 293 cell line (IC 50 = 6.4 μM), and the ultra-rapid delayed rectify K + current I Kur in human atrial myocytes (IC 50 = 8.0 μM) by binding to the open channels and showed a use- and frequency-dependent manner. In addition, trimethylapigenin decreased transient outward potassium current (I to) in human atrial myocytes, inhibited acetylcholine-activated K + current (IC 50 = 6.8 μM) in rat atrial myocytes. Interestingly, trimethylapigenin had a weak inhibition of hERG channel current. Our results indicate that trimethyapigenin significantly inhibits the atrial potassium currents hKv1.5/I Kur and I KACh, which suggests that trimethylapigenin may be a potential candidate for anti-atrial fibrillation. © 2012 Elsevier Inc. All rights reserved.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationBiochemical Pharmacology, 2012, v. 84 n. 4, p. 498-506 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.bcp.2012.05.002
dc.identifier.citeulike11092493
dc.identifier.doihttp://dx.doi.org/10.1016/j.bcp.2012.05.002
dc.identifier.hkuros202912
dc.identifier.isiWOS:000307135600011
dc.identifier.issn0006-2952
2011 Impact Factor: 4.705
2011 SCImago Journal Rankings: 0.418
dc.identifier.scopuseid_2-s2.0-84864138148
dc.identifier.urihttp://hdl.handle.net/10722/163493
dc.languageeng
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/biochempharm
dc.publisher.placeUnited States
dc.relation.ispartofBiochemical Pharmacology
dc.subjectAcetylcholine-Activated K + Current
dc.subjectHkv1.5
dc.subjectOpen Channel Blocker
dc.subjectTrimethylapigenin
dc.titleEffects of the natural flavone trimethylapigenin on cardiac potassium currents
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong Li Ka Shing Faculty of Medicine
  2. Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province
  3. Tongji Medical College
  4. Huazhong University of Science and Technology